{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:26:07Z","timestamp":1787016367986,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1124\/dmd.112.044883","type":"journal-article","created":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T22:56:08Z","timestamp":1331765768000},"page":"1183-1190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["A Novel Polymorphic Allele of Human Arylacetamide Deacetylase Leads to Decreased Enzyme Activity"],"prefix":"10.1016","volume":"40","author":[{"given":"Mai","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Takamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.044883_bib1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/geno.2000.6499","article-title":"A new human hereditary amyloidosis: the result of a stop-codon mutation in the apolipoprotein AII gene","volume":"72","author":"Benson","year":"2001","journal-title":"Genomics"},{"key":"10.1124\/dmd.112.044883_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0090-9556(24)15082-9","article-title":"Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters","volume":"28","author":"Billecke","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.044883_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.30068","article-title":"Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer\u2019s disease suggests choline acetyltransferase as a candidate deserving further study","volume":"132B","author":"Cook","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1124\/dmd.112.044883_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/dmd.112.044883_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ng1196-334","article-title":"The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin","volume":"14","author":"Davies","year":"1996","journal-title":"Nat Genet"},{"key":"10.1124\/dmd.112.044883_bib6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJMra020526","article-title":"Pharmacogenomics: drug disposition, drug targets and side effects","volume":"348","author":"Evans","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.112.044883_bib7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature02626","article-title":"Moving towards individualized medicine with pharmacogenomics","volume":"429","author":"Evans","year":"2004","journal-title":"Nature"},{"key":"10.1124\/dmd.112.044883_bib8","doi-asserted-by":"crossref","first-page":"31131","DOI":"10.1074\/jbc.M313666200","article-title":"Appropriate function of 11\u03b2-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esterase","volume":"279","author":"Frick","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.044883_bib9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bjc.6690728","article-title":"Regular use of analgesics is a risk factor for renal cell carcinoma","volume":"81","author":"Gago-Dominguez","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1124\/dmd.112.044883_bib10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/dmd.105.008623","article-title":"Detection of new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamide, in human liver microsomes and urine of prostate cancer patients","volume":"34","author":"Goda","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.044883_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1124\/dmd.111.038141","article-title":"Human paraoxonase 1 is the enzyme responsible for pilocarpine hydrolysis","volume":"39","author":"Hioki","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.044883_bib12","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/004982597239994","article-title":"Rifampin and rifabutin and their metabolism by human liver esterases","volume":"27","author":"Jamis-Dow","year":"1997","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.112.044883_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-008X(91)90128-2","article-title":"The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia","volume":"111","author":"Jensen","year":"1991","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.112.044883_bib14","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.112.044537","article-title":"Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liver","author":"Kobayashi","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.044883_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1194\/jlr.M000596","article-title":"Arylacetamide deacetylase attenuates fatty-acid-induced triacylglycerol accumulation in rat hepatoma cells","volume":"51","author":"Lo","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1124\/dmd.112.044883_bib16","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.bcp.2011.08.003","article-title":"Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine","volume":"82","author":"Nakajima","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.044883_bib17","doi-asserted-by":"crossref","first-page":"21650","DOI":"10.1016\/S0021-9258(17)31855-0","article-title":"Human liver arylacetamide deacetylase: molecular cloning of a novel esterase involved in the metabolic activation of arylamine carcinogens with high sequence similarity to hormone-sensitive lipase","volume":"269","author":"Probst","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.044883_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0006-291X(91)92005-5","article-title":"Purification and characterization of a human liver arylacetamide deacetylase","volume":"177","author":"Probst","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.112.044883_bib19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajmg.b.30846","article-title":"Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer\u2019s disease and relationships with response to treatment with donepezil and rivastigmine","volume":"150B","author":"Scacchi","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1124\/dmd.112.044883_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0165-1218(78)90031-9","article-title":"Mutagenicities of phenacetin and its metabolites","volume":"58","author":"Shudo","year":"1978","journal-title":"Mutat Res"},{"key":"10.1124\/dmd.112.044883_bib21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/jps.2600800811","article-title":"Mutagenic and analgesic activities of aniline derivatives","volume":"80","author":"Sicardi","year":"1991","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.112.044883_bib22","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1038\/sj.emboj.7601924","article-title":"An acetylation\/deacetylation cycle controls the export of sterols and steroids from S. cerevisiae","volume":"26","author":"Tiwari","year":"2007","journal-title":"EMBO J"},{"key":"10.1124\/dmd.112.044883_bib23","doi-asserted-by":"crossref","first-page":"39522","DOI":"10.1074\/jbc.M101764200","article-title":"Characterization of the rodent genes for arylacetamide deacetylase, a putative microsomal lipase, and evidence for transcriptional regulation","volume":"276","author":"Trickett","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.044883_bib24","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-04-0166","article-title":"Human CYP1B1 is regulated by estradiol via estrogen receptor","volume":"64","author":"Tsuchiya","year":"2004","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.112.044883_bib25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1006\/geno.2002.6748","article-title":"Guidelines for human gene nomenclature","volume":"79","author":"Wain","year":"2002","journal-title":"Genomics"},{"key":"10.1124\/dmd.112.044883_bib26","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1124\/dmd.109.026567","article-title":"Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis","volume":"37","author":"Watanabe","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.044883_bib27","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1124\/dmd.110.033720","article-title":"Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophen","volume":"38","author":"Watanabe","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.044883_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/carcin\/3.2.167","article-title":"Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR","volume":"3","author":"Wirth","year":"1982","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.112.044883_bib29","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ajhg.2008.04.015","article-title":"Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis","volume":"82","author":"Zhu","year":"2008","journal-title":"Am J Hum Genet"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624227069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624227069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.044883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T15:10:13Z","timestamp":1739891413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624227069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0090955624227069"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.044883","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Polymorphic Allele of Human Arylacetamide Deacetylase Leads to Decreased Enzyme Activity","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.044883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}